干眼炎症的炎症机制和抗炎疗法
Liyuan Chu1, Caiming Wang1, Hongyan Zhou1
1Department of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun, China.
Frontiers in medicine
|February 29, 2024
概括
干眼疾病涉及慢性炎症,激活像MAPK和NF-κB这样的途径. 本综述详细介绍了炎症机制和抗炎药物作用,以控制干眼症状.
科学领域:
- 眼科和免疫学 眼科和免疫学
背景情况:
- 干眼是一种常见的慢性炎症状况.
- 症状包括疲劳,刺痛和灼热感.
- 相关因素包括类风湿性疾病,糖尿病,激素障碍和隐形眼镜的使用.
研究的目的:
- 审查干眼炎症的机制.
- 为了确定干眼所涉及的关键炎症因素.
- 阐明用于干眼的抗炎药物的机制.
主要方法:
- 关于干眼炎症的文献综述.
- 炎症通路的分析 (MAPK,NF-κB).
- 检查免疫细胞激活 (巨细胞,T细胞).
主要成果:
- 干眼会激活特定的炎症通路和免疫细胞.
- 各种炎症因素有助于这种疾病.
- 抗炎药物针对这些途径和因素.
结论:
- 了解干眼炎症对于有效治疗至关重要.
- 针对特定的炎症途径提供治疗潜力.
- 持续开发的抗炎药物旨在改善干眼的管理.
相关概念视频
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Open Angle Glaucoma: Treatment
448
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
448
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Inflammatory Response I: Vascular and Cellular
11.1K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
11.1K
Inflammation
53.4K
Overview
53.4K


